226 related articles for article (PubMed ID: 35664054)
1. Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis.
Liu L; Ning X; Wei L; Zhou Y; Zhao L; Ma F; Bai M; Yang X; Wang D; Sun S
Theranostics; 2022; 12(8):3758-3775. PubMed ID: 35664054
[No Abstract] [Full Text] [Related]
2. Downregulation of fatty acid oxidation led by Hilpda increases G2/M arrest/delay-induced kidney fibrosis.
Liu L; Liu T; Jia R; Zhang L; Lv Z; He Z; Qu Y; Sun S; Tai F
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166701. PubMed ID: 36990128
[TBL] [Abstract][Full Text] [Related]
3. UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury.
Ke Q; Yuan Q; Qin N; Shi C; Luo J; Fang Y; Xu L; Sun Q; Zen K; Jiang L; Zhou Y; Yang J
Cell Death Dis; 2020 Jan; 11(1):26. PubMed ID: 31932578
[TBL] [Abstract][Full Text] [Related]
4. ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis.
Jao TM; Nangaku M; Wu CH; Sugahara M; Saito H; Maekawa H; Ishimoto Y; Aoe M; Inoue T; Tanaka T; Staels B; Mori K; Inagi R
Kidney Int; 2019 Mar; 95(3):577-589. PubMed ID: 30639234
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of KLF14 expression attenuates kidney fibrosis by inducing PPARα-mediated fatty acid oxidation.
Chen L; Sha ML; Chen FT; Jiang CY; Li D; Xu CL; Pan DS; Xu ZJ; Tang QL; Xia SJ; Sun LH; Fan GJ; Shao Y
Free Radic Biol Med; 2023 Feb; 195():132-144. PubMed ID: 36584797
[TBL] [Abstract][Full Text] [Related]
6. Rhein Improves Renal Fibrosis by Restoring Cpt1a-Mediated Fatty Acid Oxidation through SirT1/STAT3/twist1 Pathway.
Song X; Du Z; Yao Z; Tang X; Zhang M
Molecules; 2022 Apr; 27(7):. PubMed ID: 35408745
[TBL] [Abstract][Full Text] [Related]
7. STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation.
Li J; Yang Y; Li Q; Wei S; Zhou Y; Yu W; Xue L; Zhou L; Shen L; Lu G; Chen L; Tao S
Cell Death Dis; 2022 Jan; 13(1):66. PubMed ID: 35046382
[TBL] [Abstract][Full Text] [Related]
8. Impairment of PPAR
Chung KW; Lee EK; Lee MK; Oh GT; Yu BP; Chung HY
J Am Soc Nephrol; 2018 Apr; 29(4):1223-1237. PubMed ID: 29440279
[TBL] [Abstract][Full Text] [Related]
9. Role of the CTRP6/AMPK pathway in kidney fibrosis through the promotion of fatty acid oxidation.
Xie YH; Xiao Y; Huang Q; Hu XF; Gong ZC; Du J
Eur J Pharmacol; 2021 Feb; 892():173755. PubMed ID: 33245899
[TBL] [Abstract][Full Text] [Related]
10. Aristolochic acid induces renal fibrosis by arresting proximal tubular cells in G2/M phase mediated by HIF-1α.
Zhao H; Jiang N; Han Y; Yang M; Gao P; Xiong X; Xiong S; Zeng L; Xiao Y; Wei L; Li L; Li C; Yang J; Tang C; Xiao L; Liu F; Liu Y; Sun L
FASEB J; 2020 Sep; 34(9):12599-12614. PubMed ID: 32706145
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FABP5P3/miR-22 axis improves TGFβ1-induced fatty acid oxidation deregulation and fibrotic changes in proximal tubular epithelial cells of renal fibrosis.
Wang J; Zeng J; Yin G; Deng Z; Wang L; Liu J; Yao K; Long Z; Jiang X; Tan J
Cell Cycle; 2023 Feb; 22(4):433-449. PubMed ID: 36196456
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation.
Gao Z; Zhang C; Peng F; Chen Q; Zhao Y; Chen L; Wang X; Chen X
Stem Cell Res Ther; 2022 May; 13(1):191. PubMed ID: 35526054
[TBL] [Abstract][Full Text] [Related]
13. MiR-9-5p protects from kidney fibrosis by metabolic reprogramming.
Fierro-Fernández M; Miguel V; Márquez-Expósito L; Nuevo-Tapioles C; Herrero JI; Blanco-Ruiz E; Tituaña J; Castillo C; Cannata P; Monsalve M; Ruiz-Ortega M; Ramos R; Lamas S
FASEB J; 2020 Jan; 34(1):410-431. PubMed ID: 31914684
[TBL] [Abstract][Full Text] [Related]
14. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis.
Miguel V; Tituaña J; Herrero JI; Herrero L; Serra D; Cuevas P; Barbas C; Puyol DR; Márquez-Expósito L; Ruiz-Ortega M; Castillo C; Sheng X; Susztak K; Ruiz-Canela M; Salas-Salvadó J; González MAM; Ortega S; Ramos R; Lamas S
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33465052
[TBL] [Abstract][Full Text] [Related]
15. MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity.
Zhou S; Ling X; Zhu J; Liang Y; Feng Q; Xie C; Li J; Chen Q; Chen S; Miao J; Zhang M; Li Z; Shen W; Li X; Wu Q; Wang X; Liu R; Wang C; Hou FF; Kong Y; Liu Y; Zhou L
Theranostics; 2024; 14(4):1583-1601. PubMed ID: 38389852
[No Abstract] [Full Text] [Related]
16. Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation.
Xu S; Jia P; Fang Y; Jin J; Sun Z; Zhou W; Li J; Zhang Y; Wang X; Ren T; Zou Z; Ding X
Kidney Int; 2022 May; 101(5):987-1002. PubMed ID: 35227690
[TBL] [Abstract][Full Text] [Related]
17. GCN5L1 controls renal lipotoxicity through regulating acetylation of fatty acid oxidation enzymes.
Lv T; Hu Y; Ma Y; Zhen J; Xin W; Wan Q
J Physiol Biochem; 2019 Nov; 75(4):597-606. PubMed ID: 31760589
[TBL] [Abstract][Full Text] [Related]
18. C3aR Antagonist Alleviates C3a Induced Tubular Profibrotic Phenotype Transition via Restoring PPARα/CPT-1α Mediated Mitochondrial Fatty Acid Oxidation in Renin-Dependent Hypertension.
Wang C; Wang Z; Xu J; Ma H; Jin K; Xu T; Pan X; Feng X; Zhang W
Front Biosci (Landmark Ed); 2023 Oct; 28(10):238. PubMed ID: 37919077
[TBL] [Abstract][Full Text] [Related]
19. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.
Kang HM; Ahn SH; Choi P; Ko YA; Han SH; Chinga F; Park AS; Tao J; Sharma K; Pullman J; Bottinger EP; Goldberg IJ; Susztak K
Nat Med; 2015 Jan; 21(1):37-46. PubMed ID: 25419705
[TBL] [Abstract][Full Text] [Related]
20. Loss of proximal tubular transcription factor Krüppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation.
Piret SE; Attallah AA; Gu X; Guo Y; Gujarati NA; Henein J; Zollman A; Hato T; Ma'ayan A; Revelo MP; Dickman KG; Chen CH; Shun CT; Rosenquist TA; He JC; Mallipattu SK
Kidney Int; 2021 Dec; 100(6):1250-1267. PubMed ID: 34634362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
